Delaware | 93-0979187 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
11500 South Eastern Avenue, Suite 240 Henderson, Nevada | 89052 | |
(Address of principal executive offices) | (Zip Code) |
Title of each class to be so registered | Name of each exchange on which each class is to be registered |
Rights to Purchase Series B Junior Participating Preferred Stock | The NASDAQ Global Select |
Exhibit No. | Description | |
3.1 | Certificate of Designation, Preferences, and Rights of Series B Junior Participating Preferred Stock of Spectrum Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K (File No. 000-28782) filed with the SEC on December 13, 2010). | |
4.1 | Rights Agreement dated as of December 13, 2010, by and between the Company and Computershare Trust Company, N.A., as rights agent, which includes as Exhibit B the Form of Rights Certificate (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 000-28782) filed with the SEC on December 13, 2010). | |
4.2 | First Amendment to Rights Agreement, dated October 13, 2017, by and between Spectrum Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 001-35006) filed with the SEC on October 13, 2017). | |
4.3 | Second Amendment to Rights Agreement, dated March 27, 2018, by and between Spectrum Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 000-35006) filed with the SEC on March 29, 2018). |
SPECTRUM PHARMACEUTICALS, INC. | ||
Date: March 30, 2018 | By: | /s/ Kurt A. Gustafson |
Kurt A. Gustafson Executive Vice President and Chief Financial Officer |
Exhibit No. | Description | |
3.1 | Certificate of Designation, Preferences, and Rights of Series B Junior Participating Preferred Stock of Spectrum Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K (File No. 000-28782) filed with the SEC on December 13, 2010). | |
4.1 | Rights Agreement dated as of December 13, 2010, by and between the Company and Computershare Trust Company, N.A., as rights agent, which includes as Exhibit B the Form of Rights Certificate (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 000-28782) filed with the SEC on December 13, 2010). | |
4.2 | First Amendment to Rights Agreement, dated October 13, 2017, by and between Spectrum Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 001-35006) filed with the SEC on October 13, 2017). | |
4.3 | Second Amendment to Rights Agreement, dated March 27, 2018, by and between Spectrum Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 000-35006) filed with the SEC on March 29, 2018). |